Tamara Lieberman
Internal Medicine · Phoenix, AZNPI 1912029463
Payments from drug & device makers
Across 344 payments — averaging $14.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$738
- Novo Nordisk$392
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$241
- Abbott$204
- Takeda Pharmaceuticals U.S.A., Inc.$203
- plus $2K from 38 others
What the payments were for
- Food & beverage$5,03999%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,089 in reported general payments places this provider in the 90th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 46 | $53,642 |
| Repatha SureclickEvolocumab | 24 | $19,729 |
| OzempicSemaglutide | 15 | $19,653 |
| Praluent PenAlirocumab | 12 | $15,913 |
| Estradiol | 31 | $2,674 |
| SynthroidLevothyroxine Sodium | 21 | $2,463 |
| Levothyroxine Sodium | 95 | $1,308 |
| Ondansetron OdtOndansetron | 27 | $1,224 |
| Methenamine Hippurate | 13 | $1,099 |
| Rosuvastatin Calcium | 77 | $845 |
| Gabapentin | 67 | $788 |
| ValacyclovirValacyclovir Hcl | 18 | $733 |
| Duloxetine Hcl | 15 | $702 |
| Esomeprazole Magnesium | 12 | $676 |
| Nebivolol Hcl | 12 | $639 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $172 | $53,64246 claims |
| Novo NordiskOzempic | $392 | $19,65315 claims |
| AbbVieSynthroid | $1,501 | $2,46321 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $30 | $1,30895 claims |
| Almatica Pharma LLCSertraline Hcl | $36 | $17823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Phoenix
- Louise TaberPhoenix$8.5M
- Ernie RifferPhoenix$3M
- Frank LovecchioPhoenix$945K
- Allison PerrinPhoenix$861K
- Nasser HajaigPhoenix$687K
- Richard TayrienPhoenix$299K
- Sanjay ShahPhoenix$288K
- Kelly KrohnPhoenix$262K
- Paul WaxPhoenix$243K
- Paul StanderPhoenix$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.